Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dipeptidyl peptidase-like protein 6 (DPP6) is a non-catalytic, transmembrane auxiliary subunit that associates with A-type Kv4 potassium channels in neurons[1][2]. DPP6 strongly influences channel gating, current amplitude, and membrane localization, helping regulate neuronal excitability, action potential backpropagation, and dendritic signaling[1][2][3]. Besides its ion channel modulatory role, DPP6 independently promotes filopodia growth and stability, playing a critical part in synaptic formation and maintenance. DPP6 is associated with several neurological disorders (ALS, dementia, intellectual disability, Tourette’s syndrome, microcephaly, autism spectrum disorder), highlighting its importance in CNS function and development[1]. While not an enzymatically active peptidase, DPP6’s structure is related to dipeptidyl peptidases, underlining its role as a specialized regulator of potassium channel activity and neuronal signaling[1][2][3].
Not applicable directly; as an auxiliary subunit, DPP6 modulates potassium channel function, influencing gating kinetics, channel localization, and neuronal excitability[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dipeptidyl peptidase-like protein 6 (DPP6).